Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
  1. 4 Option exercise Director acquired 1,574 shares (option exercise)
  2. 4 Option exercise Director acquired 1,574 shares (option exercise)
  3. 4 Option exercise Director acquired 787 shares (option exercise)
  4. 4 Option exercise Director acquired 3,148 shares (option exercise)
  5. 4 Option exercise President and CEO acquired 1,023 shares (option exercise)
  6. 4 Grant or award Director acquired 18,711 shares (grant or award)
  7. 4 Grant or award Director acquired 23,653 shares (grant or award)
  8. 4 Grant or award Director acquired 14,108 shares (grant or award)
  9. 4 Grant or award Director acquired 9,900 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market buy Director bought 5,000 shares at $1.99 ($9,950)
  17. 4 Open-market buy President and CEO bought 25,000 shares at an average $2.05 ($51,179)
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Director acquired 3,395 shares (grant or award)
  20. 4 Grant or award Director acquired 4,629 shares (grant or award)

Page 8 of 21 · 403 filings